Testing effectiveness (Phase 2)WithdrawnNCT05614453
What this trial is testing
Tislelizumab in Combination With Sitravatinib for Recurrent/Metastatic Cervical Cancer After Platinum-Based Chemotherapy
Who this might be right for
Metastatic Cervical Cancer
Australia New Zealand Gynaecological Oncology Group